| Intrinsic Valuation of: ALKEM | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | 198 | Market Cap | ₹656B | |||||
| 2021 | - | - (-) | P/E Ratio | 28 | Total Asset | ₹177B | |||||
| 2022 | ₹8B | - (-) | Net Income | ₹22B | Total Debt | ₹3B | |||||
| 2023 | ₹14B | 87.7% (72.5%) | EBITDA | ₹30B | Total Liab | ₹53B | |||||
| 2024 | ₹17B | 16.5% (7.1%) | Opr Margin | 17.06 | Debt/Equity | 0.03 | |||||
| 2025 | ₹12B | -26.7% (-28.8%) | PreTax Margin | 16.38 | BV/Share | 957 | |||||
| 5Y Average FCF | ₹13B | 14.4% (16.9%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 7.02% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (14.4%) | ||||||||||
| 2026 | ₹14B | MBG Intrinsic Value | ₹1,770 | ||||||||
| 2027 | ₹16B | ||||||||||
| 2028 | ₹18B | ||||||||||
| 2029 | ₹19B | ||||||||||
| 2030 | ₹20B | ||||||||||
| 2031 | ₹20B | ||||||||||
| Terminal Value | ₹458B | Net Worth/Share | ₹1,040 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | ₹388B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | ₹3B | ₹3,247 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | ₹3B | WACC | 6.5% | 3,063 | 3,336 | 3,677 | 4,115 | 4,698 | |||
| Equity Value | ₹388B | 7.1% | 2,714 | 2,921 | 3,172 | 3,483 | 3,881 | ||||
| Shares Outstanding | 119,565,000 | 7.8% | 2,435 | 2,596 | 2,787 | 3,019 | 3,304 | ||||
| 8.4% | 2,207 | 2,335 | 2,485 | 2,662 | 2,876 | ||||||
| DCF Intrinsic Value | ₹3,247 | 9.0% | 2,017 | 2,121 | 2,240 | 2,380 | 2,545 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||